SAMD13 serves as a useful prognostic biomarker for hepatocellular carcinoma
Abstract Hepatocellular carcinoma (HCC) is the most common form of liver cancer and the 5-year relative overall survival (OS) rate is less than 20%. Since there are no specific symptoms, most patients with HCC are diagnosed in an advanced stage with poor prognosis. Therefore, identifying novel progn...
| Published in: | European Journal of Medical Research |
|---|---|
| Main Authors: | , , |
| Format: | Article |
| Language: | English |
| Published: |
BMC
2023-11-01
|
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s40001-023-01347-5 |